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Abstract
Prion proteins are known to misfold into a range of different aggregated forms, showing different phenotypic and
pathological states. Understanding strain specificities is an important problem in the field of prion disease. Little is known
about which PrPSc structural properties and molecular mechanisms determine prion replication, disease progression and
strain phenotype. The aim of this work is to investigate, through a mathematical model, how the structural stability of
different aggregated forms can influence the kinetics of prion replication. The model-based results suggest that prion
strains with different conformational stability undergoing in vivo replication are characterizable in primis by means of
different rates of breakage. A further role seems to be played by the aggregation rate (i.e. the rate at which a prion fibril
grows). The kinetic variability introduced in the model by these two parameters allows us to reproduce the different
characteristic features of the various strains (e.g., fibrils’ mean length) and is coherent with all experimental observations
concerning strain-specific behavior.
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Introduction
Prions are infectious agents composed solely of proteins, whose
replication does not rely upon the presence of nucleic acids [1].
Although the molecular mechanisms of prion replication are
poorly understood, the current working hypothesis is based on the
assumption that prions replicate by means of an autocatalytic
process which converts cellular prion protein (PrPC) to the
disease-associated misfolded PrP isoform (PrPSc). This process of
replication of a prion depends upon the capacity of the
pathogenic protein form to bind to and to catalyze the conversion
of existing intermediate molecules. Recent studies [2] have
observed that the prion protein can misfold into a range of
different aggregated forms derived from a continuum of PrPSc
structural conformation templates [3] from which different
phenotypic and pathological states derive. The ability of the
same encoded protein to encipher a multitude of phenotypic
states is known as the ‘‘prion strain phenomenon’’ [4]. Prion
strains are defined as infectious isolates that, when transmitted to
identical hosts, exhibit the following distinct prion disease
phenotypes:
i) Proteinase K (PK) digestion profile;
ii) Incubation time;
iii) Histopathological lesion profiles;
iv) Specific neuronal target areas.
A reason for the strain phenomenon can be the association of
PrPSc to several disease conformations, characterizable by means
of a different stability against denaturation, different post-
translational modifications (e.g. glycosylation) and distinct cleavage
sites. These observations are reinforced by [5], where it is reported
that the amyloid fibrils (formed by the 40-residues b-amyloid
peptide) with different morphologies have significantly different
molecular structures. These differences are shown to be self-
propagating and to be associated with different toxicities,
suggesting the possibility for a structural origin of prion strains.
Moreover, recent studies on prion disease have confirmed that the
incubation time is related not only to the inoculum dosage and the
prion protein expression, but also to the resistance of prion strains
against denaturation [3] in terms of the concentration of guanidine
hydrochloride (Gdn-HCl) required to denaturate 50% of the
disease-causing protein (see Text S1 for further discussions). Other
studies have highlighted a strong relationship between the stability
of the prion protein against denaturation and neuropathological
lesion profiles [6,7]. Lesions due to stable prions tend to show large
vacuolations localized in specific small brain regions, whilst lesions
due to unstable prion strains show a less intense vacuolation and
are more widely distributed in the brain. Apart from these
properties, crucial details of the molecular mechanisms enabling
the characterization of different prion strains are still missing. For
example, neither structural characterizations of PrPSc, nor maps of
protein-protein interactions have so far been provided, and even
the PrPC biological function is unclear. Hence, in order to use the
existing data to gain some insight into the properties of the
different prion strains, we decided to follow a model-based
approach.
In this paper, using a well established model for the kinetics of
the in vivo prion replication [8], we relate the evidence about
conformational stability to the parameters of the model describing
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the evolution in time of the fibril length. The main points we
deduce from our analysis are:
i) In terms of the model, the key parameter describing strain-
dependent replication kinetics is the fibril breakage rate.
ii) A precise fitting of the model prediction to the experimen-
tal data is obtained assuming that also the aggregation rate
changes with the strain. In particular, a functional dependence
on the breakage rate is assumed.
iii) The prediction of the model is that the stability against
denaturation is inversely correlated to both breakage and
aggregation rates and directly correlated with the mean length
of fibrils.
iv) By fitting experimental data, we can quantitatively predict
the fibril length distributions associated to different prion
strains.
Multiple experimental observations in vitro [9] and in yeast
[10,11] support our model-based considerations, reinforcing our
predictions for in vivo mammalian systems.
Results
Protein polymerization seems to have a central role in the
progression of the prion pathology, an aspect shared with several
other neurodegenerative diseases associated with different aggre-
gating proteins, such as Alzheimer’s (A b), Parkinson’s (a-
synuclein) and Huntington’s (huntingtin) diseases. The aggregation
kinetics of amyloid peptides has been studied extensively (see
[12,13]), and has shed light on the wide range of amyloid
aggregation mechanisms observed. Many modeling approaches
have been introduced for this purpose in recent years, e.g.
theoretical models consisting of nonlinear ordinary differential
equations (ODEs), two-dimensional lattice-based statistical models
and molecular dynamics simulations [8,13–18]. In this paper we
explore a mathematical description of the prion replication
dynamics through nonlinear ODEs. This class of models explain
the appearance of the disease by means of a bistability induced by
a quadratic term, as in classical epidemic models [19]. The model
we used is drawn from [8,14] and is based on a nucleated
polymerization mechanism [20] (see Materials and Methods). This
approach has been shown to overcome the limitations of the
‘‘heterodimer model’’ [1] and to be a reasonable simplification of
the ‘‘cooperative autocatalysis’’ approach [18]. Furthermore, it is
able to explain the kinetics of spontaneous generation [18], the
association between infectivity and aggregated PrP, the linear
appearance of the fibrils and to take into account fundamental
processes of an in vivo replication (i.e. fibrils splitting), all while
remaining relatively mathematically tractable. Moreover, its
dynamical behavior has been extensively studied [21,22], and
experimental measurements were used in [14] to provide an
estimation of the full set of parameters for a particular prion strain.
The model has three state variables (Eq. 10) describing the amount
of monomer (x), polymer (y) and the mass of polymer (z), and it
involves 6 parameters (see Table 1). We reproduce here only the
features essential to discuss the strain dependence of its
parameters; the details are covered in Materials and Methods.
In [8] it has been shown that for any prion strain two
parameters, the rate of growth (r) and the reproductive ratio (R0),
can be estimated from experimental data. The former (Eq. 2)
represents the exponential growth of the number of infectious
particles. The latter (Eq. 3) is defined as the average number of
prion fibrils that a single infectious particle can give rise to, before
splitting into fibrils smaller than a critical size or being degraded.
In other words, R0 represents the ability of the fibrils to survive to
critical breakage and degradation events. The equations for the R0
and r parameters obtained from the kinetic model of [8] can be
reparametrized in terms of the mean length of the fibrils s
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Table 1. Model symbols.
Model state variables amount of monomer x
amount of polymer y
mass of polymer z
Model parameters nucleus size n
rate of monomer production l
rate of degradation d
rate of aggregation b
rate of clearance a
rate of breakage b
Description of all state variables and parameters.
doi:10.1371/journal.pcbi.1000420.t001
Author Summary
Prion diseases are caused by the accumulation of a
cellular prion protein with an altered conformation, which
acts as a catalyst for the further recruitment and the
modification of the normal form of the protein. Protein
polymerization appears to have a central role in the
progression of the disease, an aspect shared with several
other neurodegenerative diseases. The aim of this work is
to investigate at the kinetic level the ‘‘prion strain
phenomenon’’, i.e., the ability of prion proteins to misfold
into a range of different aggregated forms exhibiting
different replication and propagation properties. The
dynamics of prion replication is investigated with the
help of a mathematical model. We relate a measurement
accessible in vitro (prion structural stability) to a
mathematical description of the fibrils’ kinetics in vivo.
The analysis of the model suggests that the replication
kinetics of the different prion strains is characterizable by
means of two parameters, representing the rates of
breakage and aggregation. This result is coherent with
various experimental findings concerning strain-specific
behavior, such as, for example, the observation of the
fibril mean length of the various strains.
Prion Strains through a Kinetic Model
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In order to estimate from experimental measures both
parameters (R0 and r) certain assumptions are necessary (see
Materials and Methods for full details). An estimation of R0 and r
from in vivo experiments and for different prion strains character-
ized by different values of stability against denaturation (G) is listed
in Table 2. The dataset currently available is limited (as not many
prion strains can be fully characterized) and many error sources
are potentially affecting the estimation of the parameters.
Nevertheless, Figure 1 shows the existence of a negative trend
between these two empirical parameters (Pearson correla-
tion =20.91, p-value = 0.01). If we now turn to the kinetic model
and look at the corresponding expressions (Eq. 2, 3) the interesting
question is whether such a behavior is predicted by the model
itself, and is explainable in terms of some of its parameters, in a
way that is both mathematically and biologically plausible.
Otherwise stated, we investigate which, if any, among the model
parameters best describe the strain variability. The critical size of
the nucleus (parameter n in the model) plays a marginal role in our
analysis and is likely to be a fixed integer, in between 2 and 4,
across different strains [23]. Even though it has been argued that a
hexamer is the minimum infectious unit [24], it can be shown that
the model-based conclusions are not conditioned by the value of n.
In addition X0 ~l=dð Þ is clearly independent of the prion strains,
so we remain with three possible choices: a, b and b. From Eq. 1,
increasing b means incrementing s and this affects R0 and r in a
similar manner, so that this parameter alone cannot explain the
inverse relationship derived in Figure 1. The same can be said for
a and n which, if increased/decreased, would induce changes of
equal sign in R0 and r. Different conclusions can be drawn when
considering b as the only strain-varying parameter. This
dependence becomes clearer assuming that fibrils cannot be
degraded in the exponential phase (a~0, identical results can be
obtained supposing that the degradation of the fibrils scales as the
fibrils breakage rate, a*b, see Text S2). Such assumption leads to
the following expressions:
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If we keep into account only the dependence from b, then Eq. 4
and Eq. 5 can be simplified to
r*b1=2 ð7Þ
R0*b{1=2: ð8Þ
From these simplified formulas it is clear that an increase in
the frangibility of the fibers (i.e., in b) produces an increment of r
(Eq. 7) and a decrement of R0 (Eq. 8) in agreement with the
trend in Figure 1. Therefore, from the model we expect
R0*f =rz1 to give the best fitting result. As a matter of fact,
this relationship (black dash-dotted line in Figure 1) does not
provide the optimal fit, although it reproduces the qualitative
observed behavior (p value~3e{4). The fittings of Figure 1
(see Table 3) suggest that, approximately, R0{1& 12 r
{0:4 (red
line) implying that we are observing R0 proportional to b
{2=7
and r to b5=7 (see Materials and Methods, Eq. 12). This means
that the estimated exponents for b are somewhat different from
the expected values of ({1=2, 1=2) predicted in Eq. 7 and 8. In
order to improve the model prediction, we introduce a strain-
dependence on a second parameter. The simplest solution
suggested by the model for this scope (deducible from Eq. 4 and
5) points to the aggregation rate b. By linking b to b, we are still
left with a one-parameter family of models describing the strain-
dependence. In doing so, we obtain the estimate b*b3=7 (see
again Materials and Methods, Eq. 13). This correction yields
R0*b{2=7 and r*b5=7, this time respecting the predictions of
Eq. 4 and 5. Therefore, on the one hand we can show that at a
qualitative level b is the only parameter that alone can explain
the inverse relationship between R0 and r. On the other hand,
the variation of b by itself is not able to quantitatively describe
the experimental data in a precise way. An additional
correction, obtained relating b to b, leads to a substantially
improved fitting. Apart from Eq. 4 and 5, our choice of b
alongside b as strain-dependent parameter is suggested by the
structure of the model of Eq. 10, in which, of all parameters,
those describing the kinetics of fibril aggregation/breakage are
the most likely to vary across strains. Both the fitting and the
model structure suggest an interplay between b and b, with b
partially balancing the effect of b.
In the following, we will describe how the previous results can
be extended to the stability to denaturation of the prion strains,
providing experimental observations in support of our claims.
From Figure 2A a direct linear proportionality between R0 and G
is inferred. Therefore, combining the fitting between G and R0
and r and R0, a similar inverse relationship (see Figure 2B) relates
G and r (see Table 3). A point of note is that a linear model (i.e.,
G~frzc) is not only associated to a low coefficient of
determination R2 but is also implausible, as it predicts negative
values of r in correspondence of very stable prion strains (such as
MK4985, see Table 4). Owing to the linear proportionality
Table 2. Estimated empirical parameters for different prion
strains.
Prion strain R0 r day
{1
 
G Mð Þ
139A – 0.05 [34] 2
ME7 3 0.024 2.9
BSE 3.48 [35] 0.015 2.8
Sc237 2 [36] 0.11 [37] 1.6
RML 2.1 [14] 0.18 [38] 1.7
MK4985 3.9 – 3.8
vCJD – 0.07 [39] 1.85 [40]
Fukuoka-1 CJD 3 [41] 0.03 [42] –
Chandler Scrapie 2 [8] 0.17 [8] 2.2
301 V – 0.07 [43] 2.2
The estimated values for the reproductive ratio (Eq. 11), rate of growth and
stability against denaturation for different prion strains are shown. One of them
(MK4985) is a synthetic prion strain that requires a high concentration of Gdn-
HCL to denature 50% of the pathogenic protein. Whenever no reference is
shown, [3] is used.
doi:10.1371/journal.pcbi.1000420.t002
Prion Strains through a Kinetic Model
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(R0~fG) of Figure 2A, the inferred functional dependencies from
b extend to G (i.e., G*b{2=7). This result, in light of the
experimental observations in [10], contributes to validate the
results of the kinetic model and provides us with a simple practical
tool to interpret prion strain stability. As a matter of fact, the
experimental data in [10] report a relationship between the
chemical stability of yeast prion strains and their structural
properties, hence reinforcing our conclusions. In particular, the
frangibility of different Sup35NM amyloid conformations was
measured and shown to be consistent with an increase in sensitivity
to denaturants and proteases. Thus, confirming the main role of
the breakage rate, as predicted here by the model. Furthermore,
the authors observed also a variation in the aggregation rate
(parameter b in the model), which was however overcome by the
stronger effect of the division rate; an additional observation in
agreement with our results, where the best match with the
experimental data is obtained for a variation of b that only
partially compensates for that of b. The importance of breakage
events for the in vivo prion propagation is also underlined in [25],
where the authors observed that membrane-anchored PrP is
necessary for the exponential growth of prion aggregates. In
transgenic mice, expressing anchorless prion protein inoculated
with different prion strains, the aggregates seem to grow
quadratically in time [26]. This feature is explainable by a linear
aggregation model (i.e setting b equal to 0). Moreover, in [26],
different prion strains show a common inability to induce the
disease. The absence of fibrils disruption can prevent the
formation of oligomeric species, thus hiding the difference between
prion strains. Our model-based analysis suggests that an
experiment monitoring the propagation of prion strains lacking
the GPI anchor would be useful to characterize in more depth the
strain phenomenon.
In the last part of the Section, we investigate how the prion
stability (G) is reflected in the mean length of the fibrils (s).
Combining the fitting of Figure 2 with Eq. 6, b (and consequently
s, from Eq. 1) can be inferred directly from G and n:
b~
r
R0{1ð Þn&
0:39
G{1
 2:63
G
0:91
{1
 
n
: ð9Þ
In Table 4, we compare the approach of Eq. 9 with the results
obtained in [14], where the authors give a complete estimation
(including a range of uncertainty) of all the parameters for the
RML prion strain (GRML~1:7 GdnHCl½ 1=2, highlighted in
bold in Table 4). The comparison between these two approaches
shows that the predictions obtained through Eq. 9 are similar to
the values reported in [14] for the RML strain. In addition, we can
compare the values of b for the strains inferred from Eq. 9, with
the ones computed using Eq. 11 and then imposing bX0 equal to
the values of [14] for the RML strain (see Figure S1). Our
predictions are approximately within the range of values
computed considering bX0 constant among strains. This result
reinforces the major role of b in explaining strain variability.
Figure 1. Relationships between the empirical parameters R0 and r. The reproductive ratio is plotted against the rate of growth. The
downward trend is not well described by the linear model with negative angular coefficient (f ) and an intercept (c) (dotted blue line). In addition, the
model prediction with b fixed (dashed-dot black line) fails to precisely represent the data, even if it provides a more reasonable relationship (notice
that high stable prions, such as MK4985, would always be associated to positive r values). Introducing one more degree of freedom (exponent h)
yields a higher R2 value (red line, R0~0:5 r
0:4z1). This result corresponds to a prediction of b*b0:43. In addition, we tested a further simplified
model version (where n is considered to be much smaller than s) according to which R0&
r
b n{1=2ð Þ (i.e. 1:3 r
0:23, shown in green). Similar
conclusions could be drawn.
doi:10.1371/journal.pcbi.1000420.g001
Prion Strains through a Kinetic Model
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Owing to the fact that b is now strain-dependent (b~b Gð Þ), we
can also predict the mean length of the fibrils (Eq. 1) for each
considered strain (see Table 4, s Gð Þ). For instance the mean length
of the fibrils population for two prion strains with different
stabilities (e.g. RecMoPrP (89–230) and Sc237) can be compared.
For the unstable prion strain (Sc237) this is approximately 7
monomer units, while for the stable prion strain (RecMoPrP (89–
230)) it is approximately 14 monomer units. This theoretical
approach provides a valuable method to simplify the model
characterization. Furthermore, it contributes to understanding the
properties associated to prion strains with different stability against
guanidine denaturation.
Discussion
While it is reasonable that the parameters of the kinetic model
might all be affected by strain specificities (i.e. stability against
denaturation), the dominant contribution seems to be due to the
susceptibility to frangibility (i.e. b), with only a minor correction
due to b. The inverse relationship between r and R0 shown in
Figure 1 is the main argument in the identification of b as the key
physical aspect differentiating prion strains. In addition, b is
suggested as the most plausible and parsimonious correcting
factor, in order to improve the data fitting.
Several aspects can influence the estimation of the parameters
and the model predictions. For example, the uncertainty affecting
the estimation of r and R0 (respectively inferred from an
exponential curve and from a ratio of exponentials); or the
possibility that the breakage rate is not equal across all the different
polymer lengths (e.g. mechanical stress can differently affects
longer fibers); or even the impact of the mouse age on the model
parameters (affecting e.g. the PrPC production rate). In spite of
these (and potentially many other) disregarded aspects character-
izing an in vivo system, this simple model is able to capture and
explain the observed data dependencies through arguments
supported by multiple independent experimental observations.
Our analysis reveals that stable prion strains can be characterized
by a ‘‘stronger’’ aggregated structure which is less prone to
breakage events. This will further imply a longer mean length of
the fibrils. Instead, unstable prion strains are subject to a higher
fragmentation rate. The role of b is essentially to partially balance
the increased breakage and is coherent with the experimental
observations in yeast. Furthermore, the increased number of
catalytic sites may be also responsible for the shorter incubation
time.
As already mentioned, such phenomenon was observed in yeast
prions [27]. The yeast prion proteins, although fundamentally
different from the mammalian prion proteins, show the same
ability to convert into aggregated forms, propagate and be
infectious. This simpler unicellular system is a valuable model as
Table 3. Fitted values for the curves in Figure 1 and Figure 2.
Relationship Estimated parameters R-square p.value
R0 vs r 0:509 r{0:38z1 0.97 3:1 e{4
{7:78rz3:283 0.83 0.0109
1:325 r{0:2268 0.96 4:34e{4
0:045 r{1z1 0.04 9:16e{4
0:255 r{0:504z1:384 0.97 2:82e{4
G vs r 0:39 r{0:38z1 0.69 0.01
{4:954 rz2:583 0.41 0.0848
1:215 r{0:2037 0.67 0.0123
0:0037 r{1z1 0.53 0.0104
0:083 r{0:675z1:53 0.7 0.0093
G vs R0 0:9118R0 0.87 0.0069
The linear and non linear relationships, with and without the intercept, for
R0 vs r and G vs r are reported here. These models are fitted to the
experimental measurements listed in Table 2. For each model the fitting
parameters, R2 and the correlation p-value are reported. When G and R0 are
related to r, the non linear model with a fixed intercept and a free exponent (i.e.
fxhz1) is associated with the best fitting results (bold). By adding one more
free parameter (i.e. fxhzc) we do not get essentially any improvement (italic).
The estimated h value for R0 vs r, without any simplification, implies r*b0:71 ,
R0*b{0:28 and b*b0:43 (see Materials and Methods). A direct proportionality is
observed also for G vs R0.
doi:10.1371/journal.pcbi.1000420.t003
Figure 2. Relationships between G, R0 and r. In (A) and (B) the stability against denaturation is plotted against the reproductive ratio and the
rate of growth. A direct proportionality links G to R0 G~0:92R0ð Þ. As expected, an inverse proportionality emerges between G and r, reinforcing the
previous results.
doi:10.1371/journal.pcbi.1000420.g002
Prion Strains through a Kinetic Model
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it enables a deeper analysis of the fibril formation process [28], not
possible to the same extent in higher organisms.
The framework proposed allows for a model-based analysis of
these properties in mammalian prions in vivo. In the context of
mammals, our results are consistent with [9], where fibrils with
different conformational stability are generated in vitro from full
length mammalian PrP. In that paper, the authors relate the
stability to the size of the smallest possible fibrillar fragment
without taking into account the kinetics of the replication
(reproducing the in vivo behavior). We draw similar conclusions
from a different point of view. As a matter of fact, we investigate
the dynamic evolution of prion propagation in a multicellular in
vivo system, in which molecular and cellular mechanisms are
present as well. Our model-based conclusions provide further
evidence that in vitro systems and yeast prion propagation
mechanisms can be transposed in mammals. Moreover, linking
the strain phenomena to dynamical features leads to a character-
ization of the evolution of the length of the fibrils in vivo.
We can, in fact, speculate (in agreement with [5]) that stable
prion strains exhibit a proliferation of longer fibrils that, upon
splitting, still manifest the same stability properties (Figure 3),
giving rise to a preferential proliferation of relatively long fibrils
with a low toxic effect. On the other hand, less stable prion strains
tend to form shorter fibrils, to proliferate faster and to be more
neurotoxic.
It is worth noting the connection with [13], where the kinetics of
aggregation of amyloid peptides is studied by means of coarse-
grained molecular dynamics. The authors showed how the relative
stability of b-prone states of a polypeptide can influence the
pathway of aggregation. Their results suggest that the b-stable
amyloids follow an aggregation pathway without intermediates,
while b-unstable amyloids seem to involve on-pathway oligomers.
The characterization of prion strains in terms of polymer mean
size is per se a significant observation. It provides a new possible
explanation of the observation that stability is correlated with
lesion profiles and vacuolation areas. Several hypotheses have
been made, such as the existence of a co-factor that supports the
conversion of distinct prion strains in precise brain regions. Here,
another possibility emerges: the increased size associated to stable
prions can decrease their ability to diffuse, and can circumscribe
them to small brain regions. On the contrary, oligomers can
spread around the brain more easily, causing a more homoge-
neous damage.
In conclusion, we show that linking the conformational stability
property of prions, acquired during in vivo propagation in
mammals, to their replication kinetic properties is achievable
through a rather simple model. For a wide range of parameters,
the model predicts that a higher breakage rate b implies shorter s
and shorter incubation time (in Figure S2 two simulations are
compared). Our model-based approach suggests that the amount
of information that can be extrapolated from the knowledge of G
goes beyond the expected incubation time.
Materials and Methods
Kinetic model
In vitro prion propagation is characterized phenomenologically
by the following properties: (i) a critical concentration threshold
below which fibrils cannot form; (ii) a delay before their
propagation (which can be eliminated by the addition of seeds
of preformed fibrils); (iii) a direct proportionality between the
initial rate of fiber growth and the monomer concentration [29].
The overall behavior resembles a sigmoidal growth curve [30]:
an exponential growth of infectious particles followed by a
plateau. The simplest description of the underlying observed
mechanism of protein aggregation consists of a slow continuous
nucleation followed by a fast autocatalytic growth. Therefore a
simple two-step model is able to reproduce the dynamics of the in
vitro prion propagation [12]. An in vivo prion propagation model
should explain the fact that the spontaneous prion-induced
disease is rare but progresses inevitably after infection, that the
incubation period is long and followed by a brief fatal clinical
disease and that prions undergo several molecular processes
within the cell (e.g. fibrils breakage, degradation, endogenous
PrPC production). The model derived in [8] is obtained as a
closed form of an infinite set of differential equations describing
the variation in time of the monomer and fibrils of each possible
length (from n to ?). The biological mechanisms taken into
account are the lengthening at the fiber end by the addition of
monomers, the degradation of polymers, and their splitting into
Table 4. Estimated model parameter b for different prion strains.
Prion strain G b Gð Þ b b X0~0:98ð Þ b b X0~2ð Þ b b X0~3:4ð Þ s Gð Þ
139A 2 0.0352 0.033 0.0665 0.1131 7.39
ME7 2.9 0.0036 0.015 0.0316 0.0538 9.36
BSE 2.8 0.0043 0.017 0.0339 0.0577 9.14
Sc237 1.6 0.2132 0.051 0.1039 0.1767 6.51
RML 1.7 0.1241 0.02 0.06 0.15 6.73
MK4985 3.8 0.0009 0.009 0.018 0.031 11.33
vCJD 1.85 0.0625 0.038 0.078 0.132 7.06
Chandler Scrapie 2.2 0.0184 0.027 0.055 0.093 7.83
301 V 2.2 0.0184 0.027 0.055 0.093 7.83
RecMoPrP (89–230) 5.1 [3] 0.0002 0.005 0.010 0.017 14.19
Using Eq. 9 and assuming n equal to 3, the breakage rate can be estimated (second column, b Gð Þ) from G. In [14] the authors provide for the RML strain (bold) a lower
and an upper bound for b X0 (0.98 and 3.4 prion/day) in addition to the best estimate (b X0~2 prion=day). The fitting obtained in Figure 2A is used here to infer R0
from G. We can fix b X0 to the values reported in [14] for different strains and estimate b (as the only varying parameter) from Eq. 11. Comparing the b values estimated
in [14] and our extrapolated values, we see contained differences (see Figure S1). This result shows that b is the main parameter explaining strain kinetic variability. A
remarkable advantage of this method is that it requires only a single rather simple experimental measurement (i.e. resistance to guanidine denaturation) in order to
predict the replication dynamics of a particular strain.
doi:10.1371/journal.pcbi.1000420.t004
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smaller polymers. Only if several monomeric PrPSc molecules
are mounted into a highly ordered seed, can further monomeric
PrPC be recruited and form amyloid aggregates. If, after the
breakage, the fibril has a length under the critical size, it
degrades instantaneously into normal PrPC monomers. The
model in Eq. 10 has three state variables, describing the amount
of monomer (x), polymer (y) and the mass of polymer (z), and it
comprises of 6 independent parameters: nucleus size (n), rates of
Figure 3. Kinetic model and prion pathways. The cartoon describes the pathways of kinetic replication of two prion strains with a different
stability against denaturation: a stable one (high G=square) and an unstable one (low G=hexagon) are drawn. These act as templates bringing the
same cellular prion protein (triangle) to the two different strain conformations (PrPC mRPrPSc &,X). The model assumes that the aggregation of
monomers to polymers produces a very fast change of conformation and that this aggregation is unfavorable below a critical size (n), which is
assumed to be independent of the prion strain in our model. The experimental data suggest that stable prions are characterized by a higher R0 and a
corresponding lower r. In the model, this is translated into strain-specificity of the rates of breakage and of aggregation (which are both lower for
stable prions). This implies that stable fibrils are longer and prefer to proliferate while maintaining themselves as fibrils larger than the nucleus size
(pathway on the left). On the contrary, unstable prions are more frangible (i.e. more sensitive to breakage), implying a shorter mean length. This
means that breakage events are more likely to be associated with the formation of very short fibrils, even under the critical size. The increase in the
aggregation rate is not enough to avoid an increased growth in the number of fibrils. We can therefore hypothesize that an apoptotic pathway is
most likely for these last strains (pathway on the right). These conclusions are in agreement with the working hypothesis of oligomer toxicity [44].
doi:10.1371/journal.pcbi.1000420.g003
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production (l), degradation (d ), aggregation (b), clearance (a) and
breakage (b):
dx
dt
~l{dx{bxyzbn n{1ð Þy
dy
dt
~{ayzb zzyð Þ{2bny
dz
dt
~bxy{az{bn n{1ð Þy:
8>>><
>>>:
ð10Þ
The assumption that a is negligible, made in Eq: 5ð Þ7 6ð Þ in
order to simplify the parameters equations, changes the qualitative
behavior of the model, that no longer has two stable steady states
but only one, which is unstable. This means that the exponential
growth will never reach a plateau. As mentioned in the text, this
does not affect our previous considerations, especially in light of
the fact that in vivo death occurs during the exponential growth
phase (see also the Text S2 for similar conclusions on the full
model).
Measuring the parameters r and R0
In this section we summarize the procedures mentioned in [8]
and adopted here to derive a measure for r and R0. The
assumptions deemed, in order to measure R0 and r from the
observed effect of different levels of PrP expression and inoculum
dosage, are as follows:
i) The linear relationship relating the incubation time to the
inoculum log dilution reflects the exponential growth of the
infectious units.
ii) The only parameter that varies between two transgenic
mice with an altered level of PrPC expression is considered to
be the PrPC production rate (l).
iii) The termination stage (animal death) occurs during the
exponential growth phase.
iv) The level of PrPSc in the brain at the termination stage
can be considered to be the same in all experiments.
Of all assumptions, the last one is the most important. It is
considered valid also for transgenic mice expressing different
quantities of cellular prion protein. Currently there is wide debate
about the cause of cell death in prion neurodegeneration. From
knockout mutants, it seems that PrPC loss of function is not
sufficient to cause cell death. What has been observed is that the
conversion of PrPC to the PrPSc isoform has a key role in the
disease. In spite of their apparent low neurotoxic effect [26],
fibrils have been proven to be the main ingredient in catalyzing
variations of protein conformation [31]. Therefore, it is
reasonable to assume that even if toxicity is not directly associated
to fibrils aggregates, it has to be closely related to their amount,
implying that a critical concentration of PrPSc is required to
provoke cell death. The current working hypothesis is that
oligomeric species are the most infectious [32] and a substantial
body of evidence suggests that they are also highly cytotoxic [33].
According to the previous observations, a possible explanation is
that an equal mass of prion fibrils with smaller mean size provides
a larger number of active sites for catalysis, hence inducing a
higher lethality.
In order to extrapolate a measure for r we follow the method
described in [8] based on relating the incubation time td to the
inoculum dose and implying an exponential growth in the
number of infectious particles. Taking advantage of these data
(e.g. incubation time vs inoculum dosage), we can infer the r
parameter just by fitting an exponential growth curve. More
precisely, before inoculation of prions, PrP (x) can be considered
at steady state (X0~l=d). After inoculation, it is reasonable to
assume that it remains almost constant for a while. According to
the model equations, the steady state of the mean polymers
distribution length (s in Eq. 1), is typically reached before the
exponential phase. Immediately after reaching s, the polymer
amount (y) and the polymer mass (z) start to grow exponentially.
Thus, r is defined as the dominant mode of this exponential
growth (i.e., y tð Þ~y 0ð Þert) (Eq. 2).
To have an indirect measurement of R0, the inverse relationship
between incubation time td and the PrP expression is exploited.
We take into account the previous assumptions reporting that the
number of infectious units in two inoculated mice expressing
different level of PrP (l0, l1) at the times of death (td0, td1) can be
considered almost equal. Thus imposing y 0ð Þer0td0~y 0ð Þer1td1 we
can derive R0:
R0~
1{u
1=
ﬃﬃ
v
p
{u
&
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
bX0b
p
azb n{1=2ð Þ ð11Þ
where u~td0=td1 and v~l0=l1.
For a more detailed description see Appendix of [8]. It is worth
noticing that the incubation times listed in [3] are not the same as
those used to estimate r (see Text S1 for more details).
Computing the b and b exponents
Rather that using Eq. 7 and 8, the exponents w and y such that
R0*bw, r*by can be computed from the fitted curve in Figure 1.
We approximate the numerical value 0.38 of Table 3 with 0.4 (i.e.
R0*r{
2
5). From the above expressions, b~r
1
y, which yields
R0*bw*r
w
y*r{
2
5, i.e., wy~{
2
5
or y~{ 5
2
w. Examples of values
on this line are:
w,yð Þ~ { 1
2
,
5
4
 
, {
1
3
,
5
6
 
, {
2
7
,
5
7
 
, {
1
4
,
5
8
 
:
From Eq. 6 it is clear that the only admissible pair of values is
w,yð Þ~ { 2
7
,
5
7
 
: ð12Þ
If, following Eq. 4 and 5, we add the extra functional dependence
of b from b as b~bj, we can look for a value of j that satisfies
simultaneously
R0*b
j
2b{
1
2*b
j{1
2
r*b
j
2b
1
2*b
jz1
2 :
yielding:
b
j{1
2 * b
jz1
2
 {2
5
j{1
2
~{
jz1
5
j~
3
7
~0:43:
ð13Þ
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Supporting Information
Figure S1 Plot of Table 4
Found at: doi:10.1371/journal.pcbi.1000420.s001 (0.03 MB PDF)
Figure S2 Disease evolution for different values of b
Found at: doi:10.1371/journal.pcbi.1000420.s002 (0.05 MB PDF)
Text S1 Incubation time (t_G) vs stability (G) and rate of growth
(r)
Found at: doi:10.1371/journal.pcbi.1000420.s003 (0.12 MB PDF)
Text S2 Full model considerations
Found at: doi:10.1371/journal.pcbi.1000420.s004 (0.04 MB PDF)
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